Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
about
Anti-angiogenic agents in metastatic colorectal cancerDynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitorsAngiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptorImaging in clinical trials.Medical imaging in new drug clinical development.Targeted antitumour therapy--future perspectives.Model-based treatment optimization of a novel VEGFR inhibitor.Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiationVascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats.Dynamic contrast-enhanced MRI for oncology drug development.Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.
P2860
Q26801911-5E3B9AB8-3C80-42A7-816C-CAC8A5DC4309Q30992467-68D63C2F-187C-4D91-A483-67C5068AA0B7Q33691348-05551733-4FA2-454C-BBF3-47C207F80011Q33703706-274C18FD-3AE9-41FB-8C56-0F90C7A961FCQ34256382-AEF9DF84-9929-4869-8FD4-24B12E8FAE95Q35667744-8FBB6571-FD70-4E38-8033-E8D8C1D4CEA5Q36616922-1FBE1415-C803-43F6-93AC-181A72D0CED8Q36779136-AEA9F795-2135-4008-948A-FF4622D95433Q36876370-1D882C3F-F54A-46AC-AB46-B0F85E8D374BQ36891571-A56B9FD8-95B3-46BF-A354-9065AE035C37Q37264299-DB4FB11D-4257-4D53-A907-5C8B7B767EBFQ38725827-64794436-3F5D-4005-B87B-4B32C6AD1909Q42273298-77F846CF-3DF9-4205-9D47-405D72DAE58DQ48541561-5E1542AB-1576-4DDB-B211-5FAC018392A6
P2860
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
@ast
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
@en
type
label
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
@ast
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
@en
prefLabel
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
@ast
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
@en
P2093
P1433
P1476
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
@en
P2093
Anne L Thomas
Clemens Unger
Dirk Laurent
Joachim Drevs
Margaret Dugan
Udo Vanhoefer
William P Steward
P356
10.1016/S0093-7754(03)00123-4
P433
P577
2003-06-01T00:00:00Z